CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH

CTSA 儿科研究基础设施

基本信息

  • 批准号:
    8364991
  • 负责人:
  • 金额:
    $ 214.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. Despite great scientific advances over the past decade, the translation of these discoveries to the benefit of patients has been hampered by a number of traditional barriers. The overall goal of the Mount Sinai institutes of Clinical & Translational Sciences is to establish a new research paradigm at Mount Sinai, which will create an integrated multidisciplinary environment that will enable translation of cutting-edge research more quickly and easily from "bench-to-bedside-to-implementation" in the community; train and create an "academic home" for the clinical and translational investigators of tomorrow; and supply the governance, facilities, resources and opportunities needed to elevate the clinical research enterprise so that clinical investigators can take full advantage of Mount Sinai's Translational Research Institutes and potential collaborators in Mount Sinai Hospital and its affiliates, the School of Medicine and partnering institutions, and other CTSA programs around the country. This transformation will be achieved by fulfilling the following Specific Aims: (1) redesign the institutional research enterprise infrastructure and governance by integrating research functions across administrative, departmental and intellectual boundaries, enhancing and promoting interactions between basic scientists and clinical investigators, and streamlining administrative procedures to facilitate the start-up of clinical trials and the dissemination of results; (2) establish a Translational Discoveries Program to facilitate and expedite clinical research by providing consultation, oversight and facilities for clinical and translational research, engaging the surrounding community and our affiliates to rapidly translate health benefits to the general population, and developing new methodologies to improve clinical trial design and reduce participant burden; (3) train and support the translational investigators of tomorrow by overseeing a multi-disciplinary, doctoral degree-granting program in clinical and translational research for all health care professionals, developing a program to recruit, enhance career development and retain clinical and translational researchers, providing an academic home where new collaborations can be formulated; (4) establish an Experimental Therapeutics& Technologies Program to stimulate the development of new methodologies in clinical and translational research by developing an institution-wide mentored program to identify and develop novel clinical and translational research projects; and (5) establish an institution-wide biomedical information infrastructure that can connect basic researchers, clinical researchers, caregivers and laboratories with an integrated network of information. RELEVANCE (See instructions): The establishment ofthe Mount Sinai Institutes of Clinical & Translational Sciences would create an effective, efficient and centralized research administrative structure, foster and reward interdisciplinary collaborations, educate and retain the clinical and translational investigators of the future, enable translation of basic scientific discoveries into clinical practice, and deliver to our diverse community new therapies and a standard of care that would have been unimaginable even five years ago.
这个子项目是对CTSA资金的百分比的估计

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hugh A Sampson其他文献

Standardization of anti-asthma herbal formula MSSM-002 by HPLC chromatographic fingerprint
  • DOI:
    10.1016/s0091-6749(02)81886-3
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Zhong-Mei Zou;Hugh A Sampson;Xiu-Min Li
  • 通讯作者:
    Xiu-Min Li
The Chinese herbal formula, MSSM-002, can reverse the established Th2 phenotype, which is accompanied with down regulation of the th2 transcription factor GATA-3
  • DOI:
    10.1016/s0091-6749(02)81592-5
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Xiu-Min Li;Ariel Teper;Zhong-Mei Zou;Kamal D Srivastava;Brian H Schofield;Hugh A Sampson
  • 通讯作者:
    Hugh A Sampson
Detection of milk proteins in dry powder inhalers containing lactose
  • DOI:
    10.1016/s0091-6749(02)81924-8
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anna H Nowak-Wegrzyn;Ludmilla Bardina;Kirsten Beyer;Wayne G Shreffler;Hugh A Sampson
  • 通讯作者:
    Hugh A Sampson
Effects of preparation methods on the allergenicity of peanut in a murine model of peanut-induced anaphylaxis
  • DOI:
    10.1016/s0091-6749(02)81676-1
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hayf Emeil Al-Mussawir;Kamal D Srivastava;Kirsten Beyer;Jin-Hua Li;Side Li;Wesley Burks;Gary A Bannon;Xiu-Min Li;Hugh A Sampson
  • 通讯作者:
    Hugh A Sampson
Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study
重复肾上腺素给药时间以告知儿科过敏反应观察期:一项回顾性队列研究
  • DOI:
    10.1016/s2352-4642(25)00139-7
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    15.500
  • 作者:
    Timothy E Dribin;Hugh A Sampson;Yin Zhang;Stephanie Boyd;Nanhua Zhang;Kenneth A Michelson;Mark I Neuman;David C Brousseau;Rakesh D Mistry;Stephen B Freedman;Paul L Aronson;Kelly R Bergmann;Brittany Boswell;Sri S Chinta;Wee-Jhong Chua;Ari R Cohen;Joanna S Cohen;Alicia Daggett;Justin R Davis;Julia F Freeman;Seth Woolf
  • 通讯作者:
    Seth Woolf

Hugh A Sampson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hugh A Sampson', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8848939
  • 财政年份:
    2013
  • 资助金额:
    $ 214.51万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8364992
  • 财政年份:
    2011
  • 资助金额:
    $ 214.51万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8364993
  • 财政年份:
    2011
  • 资助金额:
    $ 214.51万
  • 项目类别:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
  • 批准号:
    8364990
  • 财政年份:
    2011
  • 资助金额:
    $ 214.51万
  • 项目类别:
MOUNT SINAI INSTITUTES FOR CLINICAL AND TRANSLATIONAL SCIENCES
西奈山临床和转化科学研究所
  • 批准号:
    8364989
  • 财政年份:
    2011
  • 资助金额:
    $ 214.51万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
  • 批准号:
    8173753
  • 财政年份:
    2010
  • 资助金额:
    $ 214.51万
  • 项目类别:
Immunologic Responses to Cow's Milk Proteins in IgE-mediated Cow's Milk Allergy
IgE 介导的牛奶过敏中牛奶蛋白的免疫反应
  • 批准号:
    8034293
  • 财政年份:
    2010
  • 资助金额:
    $ 214.51万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8173755
  • 财政年份:
    2010
  • 资助金额:
    $ 214.51万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8173754
  • 财政年份:
    2010
  • 资助金额:
    $ 214.51万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8022462
  • 财政年份:
    2010
  • 资助金额:
    $ 214.51万
  • 项目类别:

相似海外基金

Support for Institutes and Research Groups on Qualitative and Multi-Method Research: 2024-2026
对定性和多方法研究机构和研究小组的支持:2024-2026
  • 批准号:
    2343087
  • 财政年份:
    2024
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Standard Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
  • 批准号:
    2317573
  • 财政年份:
    2024
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
  • 批准号:
    2317570
  • 财政年份:
    2024
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
  • 批准号:
    2317572
  • 财政年份:
    2024
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
  • 批准号:
    2317569
  • 财政年份:
    2024
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
  • 批准号:
    2317571
  • 财政年份:
    2024
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Standard Grant
NATIONAL INSTITUTES OF HEALTH (NIH), INTRAMURAL RESEARCH PROGRAM (IRP), GENE THERAPY TASK FORCE (GTTF), CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), SPECIALIZED SUPPORT SERVICESS4 AX
美国国立卫生研究院 (NIH)、校内研究计划 (IRP)、基因治疗工作组 (GTTF)、合同开发和制造组织 (CDMOS)、专业支持服务4 AX
  • 批准号:
    10950093
  • 财政年份:
    2023
  • 资助金额:
    $ 214.51万
  • 项目类别:
AI Institutes Virtual Organization (AIVO): Expanding the Network
人工智能研究所虚拟组织 (AIVO):扩展网络
  • 批准号:
    2332864
  • 财政年份:
    2023
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Standard Grant
Statement of Interest for the 2024 Canadian Institutes of Health Research (CIHR) Institute of Aging Summer Program in Aging; Proposed Career Path; Research Proposal
2024 年加拿大健康研究所 (CIHR) 老龄化研究所夏季项目的兴趣声明;
  • 批准号:
    497847
  • 财政年份:
    2023
  • 资助金额:
    $ 214.51万
  • 项目类别:
SBIR Phase I: A novel method to scaling mentoring and career development in Institutes of Higher Education
SBIR 第一阶段:一种扩大高等教育机构指导和职业发展的新方法
  • 批准号:
    2232502
  • 财政年份:
    2023
  • 资助金额:
    $ 214.51万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了